Sutro Biopharma's total assets for Q1 2026 were $241.99M, an increase of 39.21% from the previous quarter. STRO total liabilities were $308.88M for the fiscal quarter, a 0.85% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.